Bearish Bets: 3 Stocks Getting Hammered With Little Chance to Recover
How to short three stocks that cannot keep up with a bullish market.
Weekly Roundup: September Is Living Up to Its Reputation
During the week of challenging developments, we refreshed out shopping list, exited one holding and added to four others.
Don’t Confuse Speculation With a Healthy Turn
When the best-performing stocks on your screen are micro-cap junk and crypto, that is just money chasing action.
When Warren Buffett Called the Trading Floor
‘Hello, this is Warren.’ Why Buffett’s two calls to the trading floor left me starstruck and how I view Berkshire stock as the Oracle of Omaha steps aside.
Buying More Shares of This Holding Off the Discount Rack
As we make this move, we’ll replace it on our shopping list with another holding.
2 Names I’m Adding to as Expirations Create Dry Powder
Here are the top two positions worthy of additions as my cash position grows.
Wells Fargo’s ‘Rare’ Downgrade Brings Fresh Pressure to Netflix Shares
Here are the technical levels we’re tracking as we break down the firm’s move.
New Ocular Therapeutix Target Price Amid Support
The small-cap firm is likely to see defense by professional managers.
We’re Buying This Blue Chip Investment Bank on a Pullback
Goldman Sachs has pulled back to a technically favorable level. Here’s what to know.
Investors Are Out of Position — And That Is Supporting the Indexes
Why being wrong-footed makes for a market that is harder to knock down. Plus, the most underappreciated development this week.